Osaka, Japan

Shiho Kodama

This inventor holds 1 USPTO granted patent. Top assignee: Asubio Pharma Co. Ltd.. Active years: 2007.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shiho Kodama: Innovator in Hematopoietic Stem Cell Research

Introduction

Shiho Kodama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of hematopoietic stem cell research. His work focuses on developing methods to promote the growth and differentiation of these vital cells.

Latest Patents

Kodama holds a patent titled "Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin." This invention aims to provide promoters that enhance the growth and differentiation of hematopoietic stem cells and progenitors. These promoters are particularly useful as therapeutics for diseases resulting from insufficient growth or differentiation of these cells, such as panhematopenia and conditions associated with hematopoietic hypofunction. The invention utilizes Cofilin as an active ingredient to achieve its objectives.

Career Highlights

Kodama is affiliated with Asubio Pharma Co. Ltd., where he continues to advance his research. His innovative work has garnered attention in the scientific community, contributing to the understanding of hematopoietic stem cell biology.

Collaborations

He collaborates with notable colleagues, including Kenju Miura and Munetada Haruyama. Their combined expertise enhances the research efforts in the field of hematopoietic stem cells.

Conclusion

Shiho Kodama's contributions to hematopoietic stem cell research are invaluable. His innovative patent and ongoing work at Asubio Pharma Co. Ltd. highlight his commitment to advancing therapeutic options for critical health conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…